Pesquisas alternativas:
live rather » naive rather (Expandir a Pesquisa), live farther (Expandir a Pesquisa), size rather (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
de novel » de novela (Expandir a Pesquisa), die novel (Expandir a Pesquisa), de nove (Expandir a Pesquisa)
de level » de leval (Expandir a Pesquisa), de leve (Expandir a Pesquisa), de leves (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
live rather » naive rather (Expandir a Pesquisa), live farther (Expandir a Pesquisa), size rather (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
de novel » de novela (Expandir a Pesquisa), die novel (Expandir a Pesquisa), de nove (Expandir a Pesquisa)
de level » de leval (Expandir a Pesquisa), de leve (Expandir a Pesquisa), de leves (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
1
Por Wang, Wei-Peng, Ho, Pui Yan, Chen, Qiu-Xia, Addepalli, Balasubrahmanyam, Limbach, Patrick A., Li, Mei-Mei, Wu, Wen-Juan, Jilek, Joseph L., Qiu, Jing-Xin, Zhang, Hong-Jian, Li, Tianhong, Wun, Theodore, White, Ralph DeVere, Lam, Kit S., Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Ho, Pui Yan, Duan, Zhijian, Batra, Neelu, Jilek, Joseph L., Tu, Mei-Juan, Qiu, Jing-Xin, Hu, Zihua, Wun, Theodore, Lara, Primo N., DeVere White, Ralph W., Chen, Hong-Wu, Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2018)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Zimmermann, Maike, Wang, Si-Si, Zhang, Hongyong, Lin, Tzu-yin, Malfatti, Michael, Haack, Kurt, Ognibene, Ted, Yang, Hongyuan, Airhart, Susan, Turteltaub, Kenneth W., Cimino, George D., Tepper, Clifford G., Drakaki, Alexandra, Chamie, Karim, de Vere White, Ralph, Pan, Chong-xian, Henderson, Paul T.
Publicado no Mol Cancer Ther (2016)
“... to test the possibility that another drug in the regimen could cause a response. The mice were dosed...”Publicado no Mol Cancer Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“...Identification of novel targets is a critical first step in the drug discovery and development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por De Miranda, Briana R., Miller, James A., Hansen, Ryan J., Lunghofer, Paul J., Safe, Stephen, Gustafson, Daniel L., Colagiovanni, Dorothy, Tjalkens, Ronald B.
Publicado no J Pharmacol Exp Ther (2013)
“...There are currently no registered drugs that slow the progression of neurodegenerative diseases...”Publicado no J Pharmacol Exp Ther (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... pharmacokinetics and pharmacodynamics, and they frequently interact with food and other drugs, requiring...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por van Rijn, Richard M., Harvey, Jessica H., Brissett, Daniela I., DeFriel, Julia N., Whistler, Jennifer L.
Publicado em 2013
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... for decades or less-intensive hypomethylating therapy. The year 2017, however, witnessed US Food and Drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... exploited therapeutically. Neonatal respiratory failure can affect around 2% of all live births...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Chism, David D., De Silva, Dinuka, Whang, Young E.
Publicado no Expert Rev Anticancer Ther (2014)
“... receptors such as glucocorticoid receptor may substitute for androgen receptor. Drugs with novel mechanisms...”Publicado no Expert Rev Anticancer Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Heredia, Alonso, Latinovic, Olga S, Barbault, Florent, de Leeuw, Erik PH
Publicado no Drug Des Devel Ther (2015)
“... options due to HIV-1 resistance, side effects, or drug costs. Further, it is likely that current drugs...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Petta, Ioanna, Lievens, Sam, Libert, Claude, Tavernier, Jan, De Bosscher, Karolien
Publicado no Mol Ther (2016)
“... to investigate the unexplored potential of PPIs in drug discovery is driven by the need to find novel therapeutic...”Publicado no Mol Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... by the pineal gland and enterochromaffin cells which control sleep and gastrointestinal motility. Low levels...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Berardi, Rossana, Santoni, Matteo, Morgese, Francesca, Ballatore, Zelmira, Savini, Agnese, Onofri, Azzurra, Mazzanti, Paola, Pistelli, Mirco, Pierantoni, Chiara, De Lisa, Mariagrazia, Caramanti, Miriam, Pagliaretta, Silvia, Pellei, Chiara, Cascinu, Stefano
Publicado em 2013
“...://www.clinicaltrials.gov), aimed to evaluate the efficacy and toxicity of combined approaches and to develop novel...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Wang, Xue Yan, Lim-Jurado, Margaret, Prepageran, Narayanan, Tantilipikorn, Pongsakorn, Wang, De Yun
Publicado no Ther Clin Risk Manag (2016)
“... that it has very low potential for drug–drug interactions, and does not require dose adjustment in renal...”Publicado no Ther Clin Risk Manag (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Renna, Antonio, Vejarano, L. Felipe, De la Cruz, Ernesto, Alió, Jorge L.
Publicado no Ophthalmol Ther (2016)
“...PURPOSE: The feasibility, in terms of safety and potential efficacy, of a new drug combination...”Publicado no Ophthalmol Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Rossini, Maurizio, De Vita, Salvatore, Ferri, Clodoveo, Govoni, Marcello, Paolazzi, Giuseppe, Salvarani, Carlo, Adami, Silvano
Publicado em 2013
“... factor (TNF) administered monthly by subcutaneous injection. It is approved by the US Food and Drug...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
18
Por De Sensi, Francesco, De Potter, Tom, Cresti, Alberto, Severi, Silva, Breithardt, Günter
Publicado no Cardiovasc Diagn Ther (2015)
“... and their relevance for mechanism-based therapeutic strategies in this setting. Advances in risk stratification, drug...”Publicado no Cardiovasc Diagn Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Salzano, Giuseppina, Navarro, Gemma, Trivedi, Malav S., De Rosa, Giuseppe, Torchilin, Vladimir P.
Publicado no Mol Cancer Ther (2015)
“... novel type of non-toxic and easy-to-obtain nano-device for the combined therapy of siRNA and anti-cancer...”Publicado no Mol Cancer Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Ursini, Francesco, Russo, Emilio, De Giorgio, Roberto, De Sarro, Giovambattista, D’Angelo, Salvatore
Publicado no Ther Clin Risk Manag (2018)
“... with the different aspects of the disease, including traditional and biological disease-modifying antirheumatic drugs...”Publicado no Ther Clin Risk Manag (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo